Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imagingEli C F Dijkers, Jos G W Kosterink, Anna P Rademaker, et al.
Plos One|February 15, 2013
HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriersPetra van der Groep, Paul J van Diest, Yvonne H C M Smolders, et al.
Plos One|August 7, 2015
Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal CancerEsther de Boer, Lucia M A Crane, Marleen van Oosten, et al.
The American Journal of Surgical Pathology|January 5, 2022
Clear Cell Carcinoma (CCC) of the Cervix Is a Human Papillomavirus (HPV)-independent Tumor Associated With Poor Outcome: A Comprehensive Analysis of 58 CasesSimona Stolnicu, Georgia Karpathiou, Esther Guerra, et al.
The Journal of Pathology. Clinical Research|February 23, 2021
Variability in grading of ductal carcinoma in situ among an international group of pathologistsMaartje van Seijen, Katarzyna Jóźwiak, Sarah E Pinder, et al.
Nature Medicine|September 20, 2011
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human resultsGooitzen M van Dam, George Themelis, Lucia M A Crane, et al.
The Journal of Rheumatology|April 1, 2024
Increased Interferon Signaling in Vaginal Tissue of Patients With Primary Sjögren SyndromeAnnie Visser, Jolien F van Nimwegen, Rick Wilbrink, et al.
Cancer|March 15, 2012
Prognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastasesLaurien D C Hoefnagel, Cathy B Moelans, S L Meijer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2024
APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept studyM I E van Poelgeest, Kim E Kortekaas, Helena C van Doorn, et al.
International Journal of Cancer|December 6, 2011
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II studyRenee Vermeij, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Pageof 7